fluconazole has been researched along with P carinii Pneumonia in 19 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The test is applied on AIDS prophylaxis and paediatric trials." | 2.69 | Combining mortality and longitudinal measures in clinical trials. ( Finkelstein, DM; Schoenfeld, DA, 1999) |
| "Cryptococcal prostatitis is a rare clinical disease and has never been reported in China." | 1.51 | An AIDS patient with urine retention. ( Cheng, J; Tao, R; Xu, L; Zhao, Q; Zhu, B, 2019) |
| "Pulmonary cryptococcosis is seen in patients with T-cell deficiencies and a diagnosis is made by culture of sputum, BAL, or occasionally of pleural fluid." | 1.43 | A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted. ( Cunha, BA; Desai, A; Fe, A; Ilowite, J; Mathew, JP, 2016) |
| "Fluconazole is a widely used antifungal agent used to treat Candida spp." | 1.42 | Influence of sustained low-efficiency diafiltration (SLED-f) on interstitial fluid concentrations of fluconazole in a critically ill patient: Use of microdialysis. ( Lipman, J; Peake, SL; Roberts, JA; Roberts, MS; Sinnollareddy, MG, 2015) |
| "Pneumocystis jirovecii pneumonia has historically been one of the most common opportunistic pneumonias and life-threatening infectious complications in HIV-infected patients." | 1.33 | [Pneumocystis jirovecii pneumonia: an old disease with a new name]. ( Aleksoniene, R; Ambrozaitis, A; Matulionyte, R; Paulauskiene, R, 2006) |
| "Fluconazole has been prescribed in 7 patients as a permanent suppressive therapy and should be continued indefinitely." | 1.30 | [Pulmonary cryptococcosis during HIV infection. 15 cases]. ( Balloul, E; Cahite, I; Caubarrère, I; Couderc, LJ; Molina, JM; Saimot, AG; Wolff, M, 1997) |
| "Product-limit survival and incidence of AIDS-defining events were calculated as a function of baseline CD4 count." | 1.29 | Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. ( Cal, SX; Haslund, I; Jockusch, JD; Loss, SD; Nightingale, SD; Peterson, DM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fujie, A | 1 |
| Iwamoto, T | 1 |
| Sato, B | 1 |
| Muramatsu, H | 1 |
| Kasahara, C | 1 |
| Furuta, T | 1 |
| Hori, Y | 1 |
| Hino, M | 1 |
| Hashimoto, S | 1 |
| Wiederhold, NP | 1 |
| Patterson, TF | 1 |
| Rebholz, S | 1 |
| Boal, CWC | 1 |
| Ehrensberger, M | 1 |
| Boyle, R | 1 |
| Cushion, MT | 1 |
| Xu, L | 1 |
| Tao, R | 1 |
| Zhao, Q | 1 |
| Cheng, J | 1 |
| Zhu, B | 1 |
| Yang, JJ | 1 |
| Huang, CH | 1 |
| Liu, CE | 1 |
| Tang, HJ | 1 |
| Yang, CJ | 1 |
| Lee, YC | 1 |
| Lee, KY | 1 |
| Tsai, MS | 1 |
| Lin, SW | 1 |
| Chen, YH | 1 |
| Lu, PL | 1 |
| Hung, CC | 1 |
| Sinnollareddy, MG | 1 |
| Roberts, MS | 1 |
| Lipman, J | 1 |
| Peake, SL | 1 |
| Roberts, JA | 1 |
| Desai, A | 2 |
| Fe, A | 1 |
| Ilowite, J | 1 |
| Cunha, BA | 1 |
| Mathew, JP | 1 |
| Tascini, C | 1 |
| Ferranti, S | 1 |
| Leonildi, A | 1 |
| Menichetti, F | 1 |
| Matulionyte, R | 1 |
| Ambrozaitis, A | 1 |
| Paulauskiene, R | 1 |
| Aleksoniene, R | 1 |
| Clumeck, N | 1 |
| Teira, R | 1 |
| Nightingale, SD | 1 |
| Jockusch, JD | 1 |
| Haslund, I | 1 |
| Cal, SX | 1 |
| Peterson, DM | 1 |
| Loss, SD | 1 |
| Balloul, E | 1 |
| Couderc, LJ | 1 |
| Molina, JM | 1 |
| Cahite, I | 1 |
| Wolff, M | 1 |
| Saimot, AG | 1 |
| Caubarrère, I | 1 |
| Bani-Sadr, F | 1 |
| Hoff, J | 1 |
| Chiffoleau, A | 1 |
| Allavena, C | 1 |
| Raffi, F | 1 |
| Finkelstein, DM | 1 |
| Schoenfeld, DA | 1 |
| Vidal, F | 1 |
| Mirón, M | 1 |
| Sirvent, JJ | 1 |
| Richart, C | 1 |
| Cheng, B | 1 |
| Glick, ME | 1 |
| Wells, C | 1 |
| Lever, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial[NCT05695521] | Phase 1 | 66 participants (Anticipated) | Interventional | 2023-04-03 | Recruiting | ||
| A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation[NCT01772108] | 42 participants (Actual) | Interventional | 2013-04-30 | Terminated (stopped due to As recruitment rate was lower than anticipated) | |||
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children[NCT00000637] | Phase 3 | 819 participants | Interventional | Completed | |||
| Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)[NCT00000676] | Phase 3 | 500 participants | Interventional | Completed | |||
| A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection[NCT00000991] | Phase 3 | 600 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fluconazole and P carinii Pneumonia
| Article | Year |
|---|---|
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
18 other studies available for fluconazole and P carinii Pneumonia
| Article | Year |
|---|---|
FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bronchogenic Cyst; Candida albicans; Candidiasis; | 2001 |
The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate).
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Pneumocystis; Pneumonia, | 2022 |
An AIDS patient with urine retention.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; China; Cryptococcosis; Cryptococcus neofor | 2019 |
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Anti-Infective Agents; Arylamine N-Acetyltransferas | 2014 |
Influence of sustained low-efficiency diafiltration (SLED-f) on interstitial fluid concentrations of fluconazole in a critically ill patient: Use of microdialysis.
Topics: Adult; Antifungal Agents; Chromatography; Critical Illness; Extracellular Fluid; Fluconazole; HIV In | 2015 |
A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neof | 2016 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
[Pneumocystis jirovecii pneumonia: an old disease with a new name].
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Urinary; Antifungal Agents; Drug Combi | 2006 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Primary prophylaxis against opportunistic infections in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Clotrimazole; Dapsone; Fluconazole; Humans; Mycoses; Pentamid | 1995 |
[Treatment and prevention of main infections associated with HIV].
Topics: Adrenal Cortex Hormones; Amphotericin B; Controlled Clinical Trials as Topic; Cryptococcosis; Flucon | 1994 |
Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; AIDS-Related Opportunistic Infections; CD4-P | 1993 |
[Pulmonary cryptococcosis during HIV infection. 15 cases].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Flu | 1997 |
[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antifungal Agents; Female | 1998 |
Central nervous system pneumocystosis in AIDS: antemortem diagnosis and successful treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Ce | 2000 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Co | 1995 |
Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge.
Topics: Candidiasis, Oral; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug In | 1992 |